We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Effectiveness of Beclomethasone Dipropionate for Perennial Allergic Rhinitis

- Perennial Female, Maleergic Rhinitis (PAR)
- Completed

Study Title: Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Female, Maleergic Rhinitis

Teva Identifier: BDP-AR-401

ClinicalTrials.gov Identifier: NCT01632540

Study Status: Completed

Trial Condition(s): Perennial Female, Maleergic Rhinitis (PAR)

Interventions: Drug: Beclomethasone Dipropionate (BDP) Nasal Aerosol

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender: Female, Male

Age Range: 12 Years and older

Trial Duration: 07/01/2012 - 02/01/2014

Study Type

Observational